Get the Latest Investment Ideas Delivered Straight to Your Inbox. Subscribe


Health Technology Stock 'Set to Break Higher'
Contributed Opinion

Share on Stocktwits


Technical analyst Clive Maund charts a health technology stock whose platform allows hospitals and healthcare organizations to buy, sell and trade surplus medical equipment and supplies.

The fundamental story for H-Source Holdings Ltd. (HSI:TSX.V; HSCHF:OTCQB) in a nutshell is as follows:

A lot of new medical equipment and supplies for hospitals, some of it very expensive, ends up never being used, for various reasons. What H-Source does is to find buyers for this stuff, getting much better prices for it than would be obtained if it was in effect sold onto a secondhand market. The company appears to be doing increasingly well at this too.

On the 1-year chart we can see that its stock appears to be shaping up to make significant gains soon. In recent weeks it has battling resistance at the 17–18 cent level as it completes what is believed to be the Right Shoulder of an upsloping Head-and-Shoulders bottom, with improvement in its technical condition symbolized by the bullish moving average cross—the 50-day rising up through the 200-day—the latter flattening in readiness for turning up. Upside volume has started to build in the past few days, which still looks small thanks to the freak volume on a day last December that has resulted in an improvement in volume indicators after a long period of weakness.

On the 3-year chart we can see the origin of the resistance at the 17–18 level, which results from a considerable volume of trading just above this level, mainly during 2017. Once it breaks above this level, it should make a run at the next significant resistance level in the C$0.24–C$0.255 area. H-Source trades in reasonable volumes on the US OTC market. There are 63 million shares in issue.

H-Source Holdings website.

H-Source Holdings HSI.TSX.V (Canada), HSCHF on OTC, trading at C$0.17, $0.14 at 12.00 noon on 24th July 2018.

Clive Maund has been president of, a successful resource sector website, since its inception in 2003. He has 30 years' experience in technical analysis and has worked for banks, commodity brokers and stockbrokers in the City of London. He holds a Diploma in Technical Analysis from the UK Society of Technical Analysts.


1) Clive Maund: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: None. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: None. My company has a financial relationship with the following companies mentioned in this article: None. disclosures below. I determined which companies would be included in this article based on my research and understanding of the sector.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: H-Source Holdings. Click here for important disclosures about sponsor fees.
3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports' terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports LLC and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of H-Source Holdings, a company mentioned in this article.

Charts provided by the author. Disclosure:
The above represents the opinion and analysis of Mr Maund, based on data available to him, at the time of writing. Mr. Maund's opinions are his own, and are not a recommendation or an offer to buy or sell securities. Mr. Maund is an independent analyst who receives no compensation of any kind from any groups, individuals or corporations mentioned in his reports. As trading and investing in any financial markets may involve serious risk of loss, Mr. Maund recommends that you consult with a qualified investment advisor, one licensed by appropriate regulatory agencies in your legal jurisdiction and do your own due diligence and research when making any kind of a transaction with financial ramifications. Although a qualified and experienced stock market analyst, Clive Maund is not a Registered Securities Advisor. Therefore Mr. Maund's opinions on the market and stocks can only be construed as a solicitation to buy and sell securities when they are subject to the prior approval and endorsement of a Registered Securities Advisor operating in accordance with the appropriate regulations in your area of jurisdiction.

Want to read more about Technology and Healthcare Services investment ideas?
Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe